The 1st patient has been enrolled in the GPX IDE Trial! The #GPXembolic is a new embolic targeting tumors. It's easy to prepare and deliver and doesn’t require complicated delivery systems. #oncology #embolization #interventionalradiology #interventionaloncology https://lnkd.in/gau8xUth
Fluidx Medical Technology, Inc.
医疗设备制造业
Salt Lake City，UT 1,023 位关注者
Products under development. Not cleared/approved in any market.
关于我们
The GPX, ULTRA, and IMPASS Embolic Device platforms are under development and do not have marketing clearance or approval in any market at this time.
- 网站
-
https://www.fluidxmedical.com/
Fluidx Medical Technology, Inc.的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Salt Lake City，UT
- 类型
- 私人持股
地点
-
主要
获取路线
US，UT，Salt Lake City
Fluidx Medical Technology, Inc.员工
动态
-
If you will be at #SVIN2024, check out the poster “Accessing the Swine Middle Meningeal Artery to Evaluate a Novel Embolic Agent” highlighting the work of the Jacobs Institute using #IMPASSembolic in an MMA model. #neurointerventional #embolization #interventionalradiology
-
-
We are excited to kick off the #GPXEmbolic IDE clinical trial! The multi-national, multi-center study, led by Dr. Michael Darcy, will have trial sites across the US, Canada, and New Zealand. #oncology #embolization #interventionalradiology #interventionaloncology
-
-
#Fluidx has been featured in Utah’s Biosphere Magazine. The “Profiles in Innovation” article highlights our portfolio of embolics. #GPXembolic, #ULTRAembolic, and #IMPASSembolic products span oncology, hemorrhage, and neuro applications. #embolization #interventionalradiology #bioutah https://lnkd.in/g8xzWMVV
-
-
Going to be at #CIRSE2024? Check out poster 1473: “Evaluation of Novel Polyelectrolyte Hydrogel Embolic in Pre-Clinical Tumor and Hemorrhage Models” to learn about the #ULTRAembolic, a fast, simple solution to treat bleeds. #embolization #interventionalradiology #hemorrhage
Get ready for #CIRSE2024!? While you prepare for the IR congress of the year, you can start browsing this year’s posters via the CIRSE 2024 congress platform.? ?? Platform: https://lnkd.in/d74qvmig ?? Posters: https://t.ly/kK3zO Can't make it to Lisbon?? During the congress, numerous sessions will be streamed live and made available on demand via the platform. Get the All-Access Pass to join CIRSE 2024 online! https://t.ly/qkKIp
-
-
At #SNIS2024, MMA embolization procedures were estimated to grow by 25% annually, passing aneurysm volumes within a few years. Visibility & distal reach of #IMPASSembolic make it an excellent option for MMA embolization. #neurointerventional #embolization #interventionalradiology
-
-
The #ULTRAembolic comes ready to use and does not contain any toxic and painful solvents, unlike DMSO-based embolics. #embolization #interventionalradiology #hemorrhage
-
The #ULTRAembolic continues to pick up momentum! We can tune the hydrogel properties to offer a range of solutions from proximal to moderately distal, allowing the ULTRA portfolio to address a large array of clinical needs. #embolization #interventionalradiology #hemorrhage
-
-
Thanks to #SNIS2024 for a great meeting and to Dr. Max Mokin for sharing his work on a pre-clinical #MMAembolization model and the #IMPASSembolic. #neurointerventional #embolization #interventionalradiology
-
-
Hope you can join us today at #SNIS2024 during the 11:00 AM Didactic Session, where Dr. Max Mokin will present “A Novel Embolic Agent IMPASS in Swine Model of Middle Meningeal Artery Embolization”. #neurointerventional #embolization #MMAembolization
-